Filed pursuant to Rule 433
Issuer Free Writing Prospectus, dated February 20, 2024
Supplementing the Preliminary Prospectus Supplement, dated February 20, 2024
Registration No. 333-271537
HCA Inc.
$1,000,000,000 5.450% Senior Notes due 2031 (the “2031 notes”)
$1,300,000,000 5.600% Senior Notes due 2034 (the “2034 notes”)
$1,500,000,000 6.000% Senior Notes due 2054 (the “2054 notes”)
$700,000,000 6.100% Senior Notes due 2064 (the “2064 notes”)
(collectively, the “notes”)
Pricing Supplement
Pricing Supplement dated February 20, 2024 to HCA Inc.’s Preliminary Prospectus Supplement dated February 20, 2024. This Pricing Supplement is qualified in its entirety by reference to the Preliminary Prospectus Supplement. The information in this Pricing Supplement supplements the Preliminary Prospectus Supplement and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement. Financial information presented in the Preliminary Prospectus Supplement is deemed to have changed to the extent affected by changes described herein. Capitalized terms used in this Pricing Supplement but not defined have the meanings given them in the Preliminary Prospectus Supplement.
| | |
Terms Applicable to the 2031 notes |
| |
Issuer | | HCA Inc. |
| |
Aggregate Principal Amount | | $1,000,000,000 |
| |
Title of Security | | 5.450% Senior Notes due 2031 |
| |
Maturity Date | | April 1, 2031 |
| |
Spread to Treasury | | 120 basis points |
| |
Benchmark Treasury | | UST 4.000% due January 31, 2031 |
| |
Benchmark Treasury Price & Yield | | 98-11+ / 4.275% |
| |
Coupon | | 5.450% |
| |
Public Offering Price | | 99.845% plus accrued interest, if any, from February 23, 2024 |
| |
Yield to Maturity | | 5.475% |